CABERGOLINA Y EMBARAZO PDF

La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Goltira Voodookazahn
Country: Algeria
Language: English (Spanish)
Genre: Environment
Published (Last): 22 February 2006
Pages: 171
PDF File Size: 7.31 Mb
ePub File Size: 3.40 Mb
ISBN: 772-9-46553-851-1
Downloads: 45731
Price: Free* [*Free Regsitration Required]
Uploader: Tygoll

De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. J Clin Endocrinol Metab. However, it is not clear if this translates into clinical benefits. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size.

Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. Sobre los desenlaces incluidos en este resumen.

Comparative effects of cavergolina and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. The prolactinomas are the most common functioning pituitary tumors. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed. In the absence of menstrual period, the drug should be discontinued and confirm pregnancy.

  6ES7 138-4DF01-0AB0 PDF

Cabergolina

Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Cabergoline Comparative Study Group. Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma.

Diagnosis and treatment of yperprolactinemia: Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Cabergoline or bromocriptine for prolactinoma?. N Engl J Med. Primary medical therapy of micro- ebmarazo macroprolactinomas in men. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.

It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low. Resistance to cabergoline as compared with bromocriptine in cabergolnia Indian J Med Res. Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine. In microprolactinomas the ophthalmologic examination is no formal indication.

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Results of a national multicenter randomized double-blind study]. Pakistan Journal of Medical Sciences Online. Su principal desarrollo es la base de datos Epistemonikos www.

Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma. Osteocalcin levels in patients with microprolactinoma before and during medical treatment.

  FOXYUTILS SPLIT PDF

Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, experience with bromocriptine is higher. The hyperprolactinemia is associated with anovulation and infertility. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. Todos los estudios compararon bromocriptina versus cabergolina.

Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea.

[Update on endocrinology: management of prolactinomas during pregnancy].

Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: There is evidence that breastfeeding no increased risk for tumor growth. Middle East Fertility Society Journal. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad cabwrgolina prolongada vida media.

Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including eembarazo studies addressing the question of this article, including five randomized controlled trials.